Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H5I2NO |
| Molecular Weight | 396.951 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C2N=CC=CC2=C(I)C=C1I
InChI
InChIKey=UXZFQZANDVDGMM-UHFFFAOYSA-N
InChI=1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
DescriptionCurator's Comment: description was created based on several sources, including
https://en.wikipedia.org/wiki/Diiodohydroxyquinoline
Curator's Comment: description was created based on several sources, including
https://en.wikipedia.org/wiki/Diiodohydroxyquinoline
The quinoline derivative diiodohydroxyquinoline (INN) or iodoquinol (USAN), one of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. Iodoquinol is also used topically in other infections and may cause CNS and eye damage. It was discovered by Adco Co. and introduced as diiodohydroxyquinoline. The mechanism of action is unknown. Iodoquinol acts against the trophozoites of Entamoeba histolytica. Iodoquinol produces its amebicidal effect at the site of infection, since it is poorly absorbed from the gastrointestinal tract and can reach high concentrations in the intestinal lumen.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. | 2013-09-05 |
|
| Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. | 2007-11-01 |
|
| Acrodermatitis enteropathica-like eruption associated with combined nutritional deficiency. | 2005-10 |
|
| Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? | 2002-03-25 |
|
| Spectrofluorometric determination of erbium in seawater with 5,7-diiodoquinoline-8-ol and rhodamine 6G. | 2001-11 |
|
| The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. | 1982-04 |
|
| Chloroquine seizures. Report of four cases. | 1968-06-03 |
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/19055171
Iodoquinol 1% produced the broadest and greatest antimicrobial activity as measured by a 3-log reduction of colony-forming units active against all microbes tested following incubation times of 1 or 5 minutes, except M luteus
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
G01AC01
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
||
|
LIVERTOX |
511
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
||
|
WHO-VATC |
QG01AC01
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
||
|
EPA PESTICIDE CODE |
24003
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
63W7IE88K8
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
1613
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
1457
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
3728
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
3224
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
3435
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000082627
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
8704
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
D004103
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
m6355
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | Merck Index | ||
|
63W7IE88K8
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
DIIODOHYDROXYQUINOLINE
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
83-73-8
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
5950
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
SUB07142MIG
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
1344509
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
DTXSID6023155
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
CHEMBL86754
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
C76008
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
201-497-9
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY | |||
|
DB09115
Created by
admin on Mon Mar 31 18:16:23 GMT 2025 , Edited by admin on Mon Mar 31 18:16:23 GMT 2025
|
PRIMARY |
ACTIVE MOIETY